News & Events
-
November 28, 2018
Sharing Data to Accelerate Medicines Development and Improve Neonatal Care: Data Standards and Harmonized Definitions
Kate Costeloe, MD, Mark A. Turner, MBChB, PhD, Michael A. Padula, MD, MBI, Prakesh S. Shah, MD, Neena Modi, MD, Roger Soll, MD, Dominique Haumont, MD, Satoshi Kusuda, MD, Wolfgang Göpel, MD, Yun Sil Chang, MD, PhD, P. Brian Smith, MD, Kei Lui, MD, Jonathan M. Davis, MD, and Lynn D. Hudson, PhD, and the International Neonatal Consortium
-
November 24, 2017
Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development
Steinhorn R, Davis JM, Göpel W, Jobe A, Abman S, Laughon M, Bancalari E, Aschner J, Ballard R, Greenough A, Storari L, Thomson M, Ariagno RL, Fabbri L, Turner MA. Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development. The Journal of Pediatrics. 2017 Dec 1;191:15–21.e1.
-
October 1, 2017
Enrollment of Neonates in More Than One Clinical Trial
Davis JM, Baer GR, Portman R, Nelson R, Storari L, Aranda JV, Bax R, Zajicek A, Klein A, Turner M, Baygani S, Thomson M, Allegaert K, International Neonatal Consortium. Enrollment of Neonates in More Than One Clinical Trial. Clinical Therapeutics. 2017 Oct;39(10):1959–69.
-
June 12, 2017
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy
Turner MA, Portman RJ, Davis JM. Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy. JAMA pediatrics. 2017 Jun 12.
-
April 1, 2017
Challenges and Opportunities to Enhance Global Drug Development in Neonates
Smith AM, Davis JM. Challenges and Opportunities to Enhance Global Drug Development in Neonates. Current Opinion in Pediatrics. 2017 Apr; 29(2):149–52.